Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
29
BALY Quote, Financials, Valuation and Earnings
Last price:
$10.03
Seasonality move
:
-3.01%
Day range:
$9.55 - $10.00
52-week range:
$8.46 - $23.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.20x
P/B ratio:
0.61x
Volume:
49.4K
Avg. volume:
141.8K
1-year change:
-28.12%
Market cap:
$488.7M
Revenue:
$2.5B
EPS (TTM):
-$11.70
Analysts' Opinion
-
Consensus RatingBallys has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $12.50, Ballys has an estimated upside of 25.38% from its current price of $9.97.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing -10.33% downside risk from its current price of $9.97.
Fair Value
-
According to the consensus of 5 analysts, Ballys has 25.38% upside to fair value with a price target of $12.50 per share.
BALY vs. S&P 500
-
Over the past 5 trading days, Ballys has underperformed the S&P 500 by -9.5% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ballys does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ballys revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Ballys reported revenues of $580.4M.
Earnings Growth
-
Ballys has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Ballys reported earnings per share of -$1.75.
Enterprise value:
3.7B
EV / Invested capital:
--
Price / LTM sales:
0.20x
EV / EBIT:
--
EV / Revenue:
1.53x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-27.89x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
27.23x
Gross Profit (TTM):
$1.3B
Return On Assets:
-8.77%
Net Income Margin (TTM):
-23.17%
Return On Equity:
-162.78%
Return On Invested Capital:
-14.37%
Operating Margin:
3.1%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.3B | $2.4B | $2.5B | $611.7M | $580.4M | |
| Gross Profit | $1.2B | $1.3B | $1.3B | $334.9M | $312.6M | |
| Operating Income | $164.4M | $104.7M | -$8.6M | -$17.7M | $18M | |
| EBITDA | $54.9M | $448.3M | $137.4M | -$227.8M | $85.5M | |
| Diluted EPS | -$7.85 | -$3.50 | -$11.70 | -$5.11 | -$1.75 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $326.1M | $510.9M | $604.2M | $536.1M | $570.1M | |
| Total Assets | $2.1B | $6.4B | $6.8B | $6.6B | $7.5B | |
| Current Liabilities | $162.9M | $528.8M | $658M | $875.8M | $763.9M | |
| Total Liabilities | $1.7B | $4.9B | $5.7B | $6.2B | $6.7B | |
| Total Equity | $454.7M | $1.6B | $1B | $449.8M | $808.8M | |
| Total Debt | $1.1B | $3.5B | $3.3B | $3.7B | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $271M | $188.6M | $114M | $70.3M | $37.8M | |
| Cash From Investing | -$302.9M | -$207.8M | $97.8M | -$205.5M | $288.9M | |
| Cash From Financing | $43.2M | $65.8M | -$287.8M | $145.3M | -$363.5M | |
| Free Cash Flow | -$34.2M | -$313.6M | -$134.1M | -$119.6M | -$16.8M | |
BALY
Sector
Market Cap
$488.7M
--
Price % of 52-Week High
42.97%
--
Dividend Yield
0%
--
Shareholder Yield
3.35%
--
1-Year Price Total Return
-28.12%
--
Beta (5-Year)
1.808
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$10.61
200-day SMA
Sell
Level
$15.11
Bollinger Bands (100)
Sell
Level
9.85 - 15.53
Chaikin Money Flow
Sell
Level
-23.2M
20-day SMA
Sell
Level
$10.37
Relative Strength Index (RSI14)
Sell
Level
44.86
ADX Line
Buy
Level
22.49
Williams %R
Buy
Level
-91.1232
50-day SMA
Sell
Level
$10.38
MACD (12, 26)
Buy
Level
0.00
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
18.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.0438)
Sell
CA Score
(Annual)
Level (-2.5411)
Buy
Beneish M-Score
(Annual)
Level (-3.2654)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (3.0144)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.
Stock Forecast FAQ
In the current month, BALY has received 0 Buy ratings 5 Hold ratings, and 0 Sell ratings. The BALY average analyst price target in the past 3 months is $12.50.
-
Where Will Ballys Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ballys share price will rise to $12.50 per share over the next 12 months.
-
What Do Analysts Say About Ballys?
Analysts are divided on their view about Ballys share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ballys is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Ballys's Price Target?
The price target for Ballys over the next 1-year time period is forecast to be $12.50 according to 5 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is BALY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ballys is a Hold. 5 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BALY?
You can purchase shares of Ballys via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ballys shares.
-
What Is The Ballys Share Price Today?
Ballys was last trading at $10.03 per share. This represents the most recent stock quote for Ballys. Yesterday, Ballys closed at $9.97 per share.
-
How To Buy Ballys Stock Online?
In order to purchase Ballys stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
